Results for tag: "Tularaemia Drug"

Tularaemia is a rare, infectious disease caused by the bacterium Francisella tularensis. It is typically spread through contact with infected animals or their carcasses, or through contact with contaminated water or soil. Treatment of tularaemia typically involves antibiotics, such as streptomycin, gentamicin, and ciprofloxacin. The tularaemia drug market is a small but growing segment of the infectious diseases drug market. It is driven by the increasing prevalence of tularaemia, as well as the development of new treatments and vaccines. The market is expected to benefit from the increasing awareness of the disease and the availability of new treatments. Companies in the tularaemia drug market include GlaxoSmithKline, Pfizer, Merck, Sanofi, and Novartis. Show Less Read more